TG and Hepatitis: Only the IgG antibody against thyroglobulin was elevated during hepatitis events compared with the 12-week control samples (p=0.008, FDR=0.43) and showed an increase from baseline to the time of toxicity among hepatitis cases (p=0.036, FDR=0.84) (Supplementary Figure 2).